George Nuki

Summary

Affiliation: University of Edinburgh
Country: UK

Publications

  1. ncbi request reprint Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial
    George Nuki
    University of Edinburgh, Edinburgh, Scotland, UK
    Arthritis Rheum 46:2838-46. 2002
  2. pmc Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
    Puja P Khanna
    University of Michigan, MI, USA
    Health Qual Life Outcomes 10:117. 2012
  3. ncbi request reprint Treatment of crystal arthropathy--history and advances
    George Nuki
    Queen s Medical Research Institute, University of Edinburgh, Scotland, UK
    Rheum Dis Clin North Am 32:333-57, vi. 2006
  4. pmc A concise history of gout and hyperuricemia and their treatment
    George Nuki
    University of Edinburgh Rheumatic Diseases Unit, Scotland, UK
    Arthritis Res Ther 8:S1. 2006
  5. ncbi request reprint Colchicine: its mechanism of action and efficacy in crystal-induced inflammation
    George Nuki
    University of Edinburgh, Osteoarticular Research Group, The Queen s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, United Kingdom
    Curr Rheumatol Rep 10:218-27. 2008
  6. ncbi request reprint Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fracture
    Veena Dhillon
    Rheumatic Diseases Unit, University Department of Medicine, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland, UK
    Osteoporos Int 16:483-9. 2005
  7. ncbi request reprint British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout
    Kelsey M Jordan
    Rheumatology Department, Princess Royal Hospital, Brighton and Sussex University Hospitals Trust, UK
    Rheumatology (Oxford) 46:1372-4. 2007
  8. ncbi request reprint A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
    Gary S Hoffman
    Cleveland Clinic Foundation, Cleveland, Ohio 44915, USA
    Arthritis Rheum 46:1309-18. 2002
  9. doi request reprint In memoriam: J. Edwin Seegmiller, M.D. (1920-2006)
    Michael A Becker
    Nucleosides Nucleotides Nucleic Acids 27:554-6. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial
    George Nuki
    University of Edinburgh, Edinburgh, Scotland, UK
    Arthritis Rheum 46:2838-46. 2002
    ..To demonstrate the long-term efficacy of anakinra, a human recombinant interleukin-1 receptor antagonist, in patients with rheumatoid arthritis (RA), and to assess the long-term safety of anakinra at different daily doses...
  2. pmc Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
    Puja P Khanna
    University of Michigan, MI, USA
    Health Qual Life Outcomes 10:117. 2012
    ..The present study quantifies the impact of the presence of tophi and frequency of acute gout attacks on health-related quality of life (HRQOL), productivity, and healthcare resource utilization...
  3. ncbi request reprint Treatment of crystal arthropathy--history and advances
    George Nuki
    Queen s Medical Research Institute, University of Edinburgh, Scotland, UK
    Rheum Dis Clin North Am 32:333-57, vi. 2006
    ....
  4. pmc A concise history of gout and hyperuricemia and their treatment
    George Nuki
    University of Edinburgh Rheumatic Diseases Unit, Scotland, UK
    Arthritis Res Ther 8:S1. 2006
    ....
  5. ncbi request reprint Colchicine: its mechanism of action and efficacy in crystal-induced inflammation
    George Nuki
    University of Edinburgh, Osteoarticular Research Group, The Queen s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, United Kingdom
    Curr Rheumatol Rep 10:218-27. 2008
    ....
  6. ncbi request reprint Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fracture
    Veena Dhillon
    Rheumatic Diseases Unit, University Department of Medicine, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland, UK
    Osteoporos Int 16:483-9. 2005
    ..The aim of this study was to examine the relationship between HR-QOL, measured before DXA scanning was undertaken, and bone mineral density (BMD). Comparison of HR-QOL with the age- and sex-matched general population was also made...
  7. ncbi request reprint British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout
    Kelsey M Jordan
    Rheumatology Department, Princess Royal Hospital, Brighton and Sussex University Hospitals Trust, UK
    Rheumatology (Oxford) 46:1372-4. 2007
  8. ncbi request reprint A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
    Gary S Hoffman
    Cleveland Clinic Foundation, Cleveland, Ohio 44915, USA
    Arthritis Rheum 46:1309-18. 2002
    ....
  9. doi request reprint In memoriam: J. Edwin Seegmiller, M.D. (1920-2006)
    Michael A Becker
    Nucleosides Nucleotides Nucleic Acids 27:554-6. 2008